Verified peer comparison
Vanda Pharmaceuticals vs BlackRock ESG Capital Allocation Term Trust Financial Comparison
Direct answer
Vanda Pharmaceuticals and BlackRock ESG Capital Allocation Term Trust are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Vanda Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Vanda Pharmaceuticals Revenue
- 216,105,000 USD
- BlackRock ESG Capital Allocation Term Trust Revenue
- 216,227,545 USD
- Vanda Pharmaceuticals Operating income
- -151,168,000 USD
- BlackRock ESG Capital Allocation Term Trust Operating income
- 213,368,713 USD